SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis

被引：4

作者：

Umapathysivam, Mahesh M. ^{[1
,2
,3
,4
,5
,6
]}

Morgan, Bethany ^{[3
,4
]}

Inglis, Joshua M. ^{[3
,5
]}

Meyer, Emily ^{[3
,4
,5
]}

Liew, Danny ^{[5
]}

Thiruvenkatarajan, Venkatesan ^{[7
]}

Jesudason, David ^{[3
,4
,5
,8
]}

机构：

[1] Royal Adelaide Hosp, Endocrine & Metab Unit, Port Rd, Adelaide, SA 5000, Australia

[2] Flinders Med Ctr, Southern Adelaide Diabet & Endocrine Serv, Adelaide, SA, Australia

[3] Queen Elizabeth Hosp, Endocrine Dept, Woodville, SA, Australia

[4] Royal Adelaide Hosp, Endocrine Dept, Adelaide, SA, Australia

[5] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia

[6] Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, SA, Australia

[7] Queen Elizabeth Hosp, Anaesthet Dept, Woodville, SA, Australia

[8] Basil Hetzel Inst, Woodville, SA, Australia

来源：

JAMA NETWORK OPEN | 2024年 / 7卷 / 03期

关键词：

D O I：

10.1001/jamanetworkopen.2024.2744

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cohort study examines the natural history and response to treatment of sodium glucose cotransporter 2 (SGLT2) inhibitor-associated ketoacidosis compared with that of type 1 diabetes-associated ketoacidosis.

引用

页数：4

共 50 条

[41] SGLT2 Inhibitors and Euglycemic Ketoacidosis
Masuta, Pardeep
Johri, Geetanjali
Paul, Manju
AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (04) : E498 - E500
[42] DIABETES SGLT2 inhibitors and diabetic ketoacidosis - a growing concern
Umpierrez, Guillermo E.
NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (08) : 441 - 442
[43] Diabetic ketoacidosis with SGLT2 inhibitors
Musso, Giovanni
Saba, Francesca
Cassader, Maurizio
Gambino, Roberto
BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
[44] Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study
Nakhleh, Afif
Othman, Areen
Masri, Amin
Zloczower, Moshe
Zolotov, Sagit
Shehadeh, Naim
BIOMEDICINES, 2023, 11 (10)
[45] Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanism
Ogawa, Wataru
Hirota, Yushi
JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (04) : 879 - 882
[46] Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate Terminology
Milder, Tamara Y.
Milder, David A.
Greenfield, Jerry R.
Day, Richard O.
DRUG SAFETY, 2023, 46 (12) : 1303 - 1305
[47] Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology
Tamara Y. Milder
David A. Milder
Jerry R. Greenfield
Richard O. Day
Drug Safety, 2023, 46 : 1303 - 1305
[48] Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis
Dizon, Stephanie
Keely, Erin J.
Malcolm, Janine
Arnaout, Amel
CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 499 - 503
[49] Euglycaemic ketoacidosis from an SGLT2 inhibitor exacerbated by a ketogenic diet
Sinha, Shampa
Gavaghan, Daniel
Yew, Steven
MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (01) : 46 - +
[50] SGLT2 inhibitor-related diabetic ketoacidosis: Australian cases
Reactions Weekly, 2018, 1691 (1) : 11 - 11

← 1 2 3 4 5 →